SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93151.
  • 2
    Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 2007; 3: 72138.
  • 3
    Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 1997; 40: 160111.
  • 4
    Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010; 69: 14202.
  • 5
    Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985; 36: 1208.
  • 6
    Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 2009; 15: 3259.
  • 7
    Watanabe A, Kodera M, Sugiura K, Usuda T, Tan EM, Takasaki Y, et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004; 50: 892900.
  • 8
    Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody–HEp-2 test is a critical parameter for discriminating antinuclear antibody–positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011; 63: 191200.
  • 9
    Rosenberg AM, Semchuk KM, McDuffie HH, Ledingham DL, Cordeiro DM, Cessna AJ, et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A 1999; 57: 22536.
  • 10
    Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008; 18: 15360.
  • 11
    Uibo R, Talja I, Jogi R, Janson C, Bjornsson E, Boman G, et al. Autoantibodies in Estonia and Sweden, populations with different responses to allergens. Int Arch Allergy Immunol 1998; 117: 12630.
  • 12
    De Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D'Haese D, et al. Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993; 11: 3937.
  • 13
    Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, Perigo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 3159.
  • 14
    Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, et al. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 1990; 36: 10411.
  • 15
    Xavier RM, Yamauchi Y, Nakamura M, Tanigawa Y, Ishikura H, Tsunematsu T, et al. Antinuclear antibodies in healthy aging people: a prospective study. Mech Ageing Dev 1995; 78: 14554.
  • 16
    Hurme M, Korkki S, Lehtimaki T, Karhunen PJ, Jylha M, Hervonen A, et al. Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev 2007; 128: 4078.
  • 17
    Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 152633.
  • 18
    Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 22343.
  • 19
    Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007; 19: 4954.
  • 20
    Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 27983.
  • 21
    Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 2011; 7: 2829.
  • 22
    Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 8597.
  • 23
    Jakymiw A, Ikeda K, Fritzler MJ, Reeves WH, Satoh M, Chan EK. Autoimmune targeting of key components of RNA interference. Arthritis Res Ther 2006; 8: R87.
  • 24
    Wiik AS, Hoier-Madsen M, Forslid J, Charles P, Meyrowitsch J. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010; 35: 27690.
  • 25
    Chan EK, Fritzler MJ, Wiik A, Andrade LE, Reeves WH, Tincani A, et al, the IUIS /WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases. AutoAbSC.Org: Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007; 6: 57780.
  • 26
    Satoh M, Langdon JJ, Hamilton KJ, Richards HB, Panka D, Eisenberg RA, et al. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest 1996; 97: 261926.
  • 27
    Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and adolescent overweight and obesity. Pediatrics 2007; 120 Suppl 4: S193228.
  • 28
    Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996; 275: 123340.
  • 29
    Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 3639.
  • 30
    Hilario MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr (Phila) 2004; 43: 63742.
  • 31
    Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in “normal” children and adults. J Rheumatol 1999; 26: 9149.
  • 32
    Grimaldi CM. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol 2006; 18: 45661.
  • 33
    Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 2009; 11: 252.
  • 34
    Candore G, Grimaldi MP, Listi F, Ferlazzo V, Colonna-Romano G, Motta M, et al. Prevalence of non organ-specific autoantibodies in healthy centenarians. Arch Gerontol Geriatr Suppl 2002; 35: 7580.
  • 35
    Nilsson BO, Skogh T, Ernerudh J, Johansson B, Lofgren S, Wikby A, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 2006; 27: 2818.
  • 36
    White GL Jr, Wood SD, Rom WN. Prevalence of antinuclear antibodies in a normal male population. Mil Med 1983; 148: 5368.
  • 37
    Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970–1977. Arthritis Rheum 1985; 28: 806.
  • 38
    McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995; 38: 126070.
  • 39
    Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 1999; 42: 41520.
  • 40
    Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 1997; 40: 4415.
  • 41
    Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, et al. Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 236770.
  • 42
    Cleary MP, Grossmann ME. Obesity and breast cancer: the estrogen connection. Endocrinology 2009; 150: 253742.
  • 43
    Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010; 235: 141224.
  • 44
    Gonzalez DA, De Leon AC, Rodriguez Perez MC, Coello SD, Gonzalez Hernandez A, Fuentes RC, et al. Inverse association between obesity and antinuclear antibodies in women. J Rheumatol 2008; 35: 244951.
  • 45
    Bonarius HP, Brandsma CA, Kerstjens HA, Koerts JA, Kerkhof M, Nizankowska-Mogilnicka E, et al. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax 2011; 66: 1017.
  • 46
    Yamagata H, Akizuki M, Tojo T, Homma M. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases. Suppl Scand J Rheumatol 1986; 61: 98101.
  • 47
    Guzman L, Martinez P, Gaytan G, Arguelles E, Herrera-Esparza R. Anti-Ro antibodies in healthy mothers and their newborns. Clin Exp Rheumatol 1987; 5: 934.
  • 48
    Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls. Scand J Rheumatol 2005; 34: 4955.
  • 49
    Metskula K, Salur L, Mandel M, Uibo R. Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol Lett 2006; 106: 148.
  • 50
    Satoh M, Langdon JJ, Chou CH, McCauliffe DP, Treadwell EL, Ogasawara T, et al. Characterization of the Su antigen, a macromolecular complex of 100/102 and 200 kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 1994; 73: 13241.